These findings were further supported by Nicolau et al 5 , who demonstrated similar clinical improvements in a broader cohort with extended follow-up, thereby reinforcing the potential use of GLP-1 RAs even in patients without metabolic comorbidities
Best of all, its non-invasive, meaning theres no downtime, and you can continue with your regular routine immediately after treatment
Most reported side effects of these peptides in studied doses are mild (injection-site irritation, transient sleep or vivid dreams, headaches), but longterm, largescale human safety dataespecially for longevity useremain limited
Ozempic is often considered more effective for weight loss in non-diabetic individuals
Early nausea affects 1520% of patients during the first 12 weeks, typically resolving as your body adapts
Surprisingly, no difference between sg CBS and sgRNA controls was detected for intracellular cysteine or GSH levels (Supplementary Fig